Quantification of fibrin degradation products in glioma and meningioma patients

CAN Ö., Erdemgil Y., Yildirim Z. Z., ÖZDUMAN K., Pamir M. N., Sav A., ...More

CANCER BIOMARKERS, vol.14, no.4, pp.253-258, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 4
  • Publication Date: 2014
  • Doi Number: 10.3233/cbm-140400
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.253-258
  • Keywords: Meningioma, glioma, fibrin degradation products, DR-70, DR-70(TM) IMMUNOASSAY, CANCER, CARCINOMA, SERUM, FDP
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes


BACKGROUND: DR-70 is an immunoassay for fibrin and FDP in plasma and it has been shown useful in detection of over 14 different cancers. This study investigated the validity of the DR-70 test in gliomas as well as meningiomas.